(Q45993059)
Statements
1 reference
Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. (English)
1 reference
G Aaron DuVall
1 reference
Dino Tarabar
1 reference
Richard H Seidel
1 reference
Nancy L Elstad
1 reference
Kirk D Fowers
1 reference
1 February 2009
1 reference
1 reference
20
1 reference
2
1 reference
89-95
1 reference